Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04418076 · ClinicalTrials.gov registry record · NA
Project SMART Automated Pillbox Study
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT04418076 is a NA study that has completed, run by Yale University. The registered enrollment target is 78 participants.
The verdict
NCT04418076, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
The aim of this study is to examine the effect of mHealth tools on antiretroviral (ART) adherence and persistence among HIV-infected individuals with co-occurring cocaine use disorders (CUDs).
Interventions
- DEVICE Group A_No feedback
- DEVICE Group B_Automated feedback
- DEVICE Group C_Automated feedback + Clinician feedback
- DEVICE Group D_Automated feedback + Social Network feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2017-06-08 |
| Est. Completion | 2020-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04418076
The ClinicalTrials.gov registry entry for NCT04418076 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Group A_No feedback is the first listed.
NCT04418076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04418076 about?
NCT04418076 is a clinical study titled "Project SMART Automated Pillbox Study". The aim of this study is to examine the effect of mHealth tools on antiretroviral (ART) adherence and persistence among HIV-infected individuals with co-occurring cocaine use disorders (CUDs).
What is the current status of trial NCT04418076?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2017-06-08. Estimated completion is 2020-08-18.
What interventions are being tested in trial NCT04418076?
The interventions under investigation include: Group A_No feedback (DEVICE), Group B_Automated feedback (DEVICE), Group C_Automated feedback + Clinician feedback (DEVICE), Group D_Automated feedback + Social Network feedback (DEVICE).
Who is sponsoring clinical trial NCT04418076?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.